期刊文献+

急性ST段抬高型心肌梗塞不同时间窗溶栓疗效观察 被引量:4

The effect of thrombolytic therapy in different time on myocardial infarction patients with acute ST-segment elevation
下载PDF
导出
摘要 目的研究ST段抬高型心肌梗塞(ST-segment elevation myocardial infarction,STEMI)患者发病后不同时间窗溶栓治疗对冠脉再通影响。方法对2009年1月-2016年9月在泽普县人民医院住院的125例STEMI接受溶栓治疗患者,根据发病后不同时间窗溶栓分成≤3 h,3~6 h,6~12 h三组,比较三组血管再通率与血管再通所需的时间差异。结果三组患者血管再通率分别为90.9%,80.9%,59.7%,差异有显著性(P<0.05);血管再通所需时间分别为(46.6±31.1)min、(77.1±35.7)min、(89.2±39.5)min,三组间差异有显著性(P<0.05)。结论 STEMI溶栓治疗的获益与溶栓开始的时间密切相关,溶栓越早血管再通率越高,血管再通所需时间越短。 Objective To study the effect of thrombolytic therapy in different time window on the coronary artery recanalization for patients with acute ST-segment elevation myocardial infarction. Methods 125 patients hospitalized in our department and received STEMI thrombolytie therapy from January 2009 to September 2016 were collected. They were divided into three groups according to the different thrombolysis time window such as 3 h, 3 - 6 h and 6- 12 h Coronary artery recanalization rate and the time required for reeanalization between three groups were compared. Results The coronary artery recanalization rate in three groups were 90.9%, 80.9%, 59.7% respectively, there were significant differences between three groups (P〈0.05) ; The time required for recanalization were (46.6 ± 31.1 )minutes, (77.1± 35.7)minutes, (89.2 ±39.5)minutes respectively, and there were significant differences between three groups (P〈0.05). Conclusion The effect of STEMI thrombolytie therapy is closely related to the start treating time, the earlier time when patients were treated with thrombolytic therapy is, the higher vascular recanalization rate can get and the shorter time for recanalization will be required.
出处 《新疆医学》 2017年第4期409-411,共3页 Xinjiang Medical Journal
关键词 ST段抬高型心肌梗塞 溶栓 时间窗 疗效 ST-segment elevation myocardial infarction Thrombolytic therapy Time window Therapy effect
  • 相关文献

参考文献5

二级参考文献71

  • 1陆建辉,洪小苏,徐卫亭.急性心肌梗死介入治疗与溶栓治疗的疗效比较[J].苏州大学学报(医学版),2006,26(3):417-420. 被引量:10
  • 2Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 3高润霖.急性心肌梗死再灌注治疗策略的选择:时间就是心肌[J].中华心血管病杂志,2004,32(S2):63-65.
  • 4Cohen M, Boiangiu C, Abidi M. Therapy for ST-segment elevation myocardial infarction patients who present late or are ineligible for reperfusion therapy[ J]. J Am Coll Cardiol,2010,55 (18) : 1895- 1906. DOI : 10. 1016/j. jacc. 2009. 11. 087.
  • 5Li S,Wu Y, Du X, et al. Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in [J]. Am Heart J,2015,169(3) :349-355 2014.12. 005.
  • 6Windecker S, Hernálndez-Antolín RA, Stefanini GG, et al. Management of ST-elevation myocardial infarction according to European and American guidelines [ J ]. EuroIntervention ,2014,10 Suppl T :T23-T31. DOI : 10. 4244/EIJV 10STA5.
  • 7Brown HF. Synopsis and Review of the American College of Cardiology Foundation/American Heart Association 2013 ST- Elevation Myocardial Infarction Guideline [ J ]. AACN Adv Crit Care ,25 ( 2 ) : 142-150. DOI : 10. 1097/NCI. 0000000000000025.
  • 8Tamis-Holland JE, O'Gara P. Highlights from the 2013 ACCF/ AHA guidelines for the management of ST-elevation myocardial infarction and beyond [ J ]. Clin Cardiol, 2014,37 ( 4 ) : 252-259. DOI : 10. 1002/clc. 22258.
  • 9Ghimire G, Gupta A, Hage FG. Guidelines in review: 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction[ J]. J Nucl Cardiol,2014,21 ( 1 ) : 190-191. DOI: 10. 1007/s12350-013-9808-x.
  • 10O'Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2013,61(4):485-510.

共引文献2596

同被引文献39

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部